These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 1531820

  • 1. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
    Rickels K, Amsterdam J, Clary C, Fox I, Schweizer E, Weise C.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
    Kiev A.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
    [Abstract] [Full Text] [Related]

  • 3. A placebo-controlled trial of paroxetine in the treatment of major depression.
    Smith WT, Glaudin V.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():36-9. PubMed ID: 1531822
    [Abstract] [Full Text] [Related]

  • 4. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
    Feighner JP, Boyer WF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
    [Abstract] [Full Text] [Related]

  • 5. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [Abstract] [Full Text] [Related]

  • 6. The safety and efficacy of paroxetine compared with placebo in a double-blind trial of depressed outpatients.
    Claghorn JL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():33-5. PubMed ID: 1531821
    [Abstract] [Full Text] [Related]

  • 7. A double-blind comparison of paroxetine, imipramine, and placebo in major depression.
    Shrivastava RK, Shrivastava SH, Overweg N, Blumhardt CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825
    [Abstract] [Full Text] [Related]

  • 8. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB, Wilcox CS.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [Abstract] [Full Text] [Related]

  • 9. Two combined, multicenter double-blind studies of paroxetine and doxepin in geriatric patients with major depression.
    Dunner DL, Cohn JB, Walshe T, Cohn CK, Feighner JP, Fieve RR, Halikas JP, Hartford JT, Hearst ED, Settle EC.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():57-60. PubMed ID: 1531827
    [Abstract] [Full Text] [Related]

  • 10. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB, Crowder JE, Wilcox CS, Ryan PJ.
    Psychopharmacol Bull; 1990 Feb; 26(2):185-9. PubMed ID: 2146697
    [Abstract] [Full Text] [Related]

  • 11. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 12. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Dec; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 13. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
    Schweizer E, Feighner J, Mandos LA, Rickels K.
    J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246
    [Abstract] [Full Text] [Related]

  • 14. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM.
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [Abstract] [Full Text] [Related]

  • 15. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP, Gardner EA, Johnston JA, Batey SR, Khayrallah MA, Ascher JA, Lineberry CG.
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [Abstract] [Full Text] [Related]

  • 16. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
    Peselow ED, Filippi AM, Goodnick P, Barouche F, Fieve RR.
    Psychopharmacol Bull; 1989 Aug; 25(2):267-71. PubMed ID: 2532373
    [No Abstract] [Full Text] [Related]

  • 17. The safety profile of paroxetine.
    Boyer WF, Blumhardt CL.
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J, Reimherr F, Marcus RN, Roberts DL, Francis RJ, Anton SF.
    J Clin Psychiatry; 1995 Feb; 56 Suppl 6():30-6. PubMed ID: 7649971
    [Abstract] [Full Text] [Related]

  • 19. Nefazodone: aspects of efficacy.
    Rickels K, Robinson DS, Schweizer E, Marcus RN, Roberts DL.
    J Clin Psychiatry; 1995 Feb; 56 Suppl 6():43-6. PubMed ID: 7649973
    [Abstract] [Full Text] [Related]

  • 20. Placebo-controlled trial of venlafaxine for the treatment of major depression.
    Schweizer E, Weise C, Clary C, Fox I, Rickels K.
    J Clin Psychopharmacol; 1991 Aug; 11(4):233-6. PubMed ID: 1918421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.